Boston Scientific's UK Arm Hit With German Stent Sale Ban

Law360, New York (May 14, 2013, 4:33 PM EDT) -- A German court has blocked Boston Scientific Corp.'s British unit from marketing or selling in the country several categories of drug-eluting stents found previously to infringe patents held by OrbusNeich Co. Ltd., the drugmaker said Tuesday.

The Dusseldorf Regional Court issued a second preliminary injunction in as many months against Boston Scientific after finding the company's stent systems infringe OrbusNeich patents. OrbusNeich said in a statement that Boston Scientific had attempted to shift its German distribution of the stent products to its U.K. subsidiary to circumvent...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.